166 related articles for article (PubMed ID: 7491786)
1. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.
Hilton MJ; Mounghane D; McLean T; Contractor NV; O'Neil J; Carpenter K; Bachenheimer SL
Virology; 1995 Nov; 213(2):624-38. PubMed ID: 7491786
[TBL] [Abstract][Full Text] [Related]
2. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
4. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
Good L; Dimri GP; Campisi J; Chen KY
J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus induces intracellular redistribution of E2F4 and accumulation of E2F pocket protein complexes.
Olgiate J; Ehmann GL; Vidyarthi S; Hilton MJ; Bachenheimer SL
Virology; 1999 Jun; 258(2):257-70. PubMed ID: 10366563
[TBL] [Abstract][Full Text] [Related]
6. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
7. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
8. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
9. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
10. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
[TBL] [Abstract][Full Text] [Related]
12. Changes in E2F DNA-binding activity during induced erythroid differentiation.
Richon VM; Venta-Perez G
Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
[TBL] [Abstract][Full Text] [Related]
13. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
[TBL] [Abstract][Full Text] [Related]
16. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
[TBL] [Abstract][Full Text] [Related]
17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
18. An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum.
Porcu P; Graña X; Li S; Swantek J; De Luca A; Giordano A; Baserga R
Oncogene; 1994 Aug; 9(8):2125-34. PubMed ID: 8035997
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2.
Kalma Y; Marash L; Lamed Y; Ginsberg D
Oncogene; 2001 Mar; 20(11):1379-87. PubMed ID: 11313881
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors.
Picon A; Bertagna X; de Keyzer Y
Oncogene; 1999 Apr; 18(16):2627-33. PubMed ID: 10353606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
